Acupuncture for the Treatment of Medication-Dependent Hypotension in Heart Failure

NCT ID: NCT04952935

Last Updated: 2021-07-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE1/PHASE2

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-04-20

Study Completion Date

2022-07-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Acupuncture is believed to increase blood pressure in people who struggle with low blood pressure. This is a common problem facing people with heart failure, and sometimes these people need to take medications to artificially increase their blood pressure. This study is designed to determine if using acupuncture in people with heart failure can improve their blood pressure enough to not require medications to artificially increase blood pressure.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Congestive Heart Failure Hypotension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized double-blinded sham-controlled clinical trial
Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors
Patient receives true or sham acupuncture, and patient is unaware of treatment assignment. Acupuncturist is aware of treatment assignment, as is the statistician who is aware of randomization assignment but not involved otherwise in the execution of clinical trial. Investigators, medical assistants, and patients' physicians are unaware of treatment assignment.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

True Acupuncture

Group Type EXPERIMENTAL

True Acupuncture

Intervention Type PROCEDURE

Delivery of four acupuncture seeds (no needles involved) to the head and neck area at true acupuncture points.

Sham Acupuncture

Group Type SHAM_COMPARATOR

Sham Acupuncture

Intervention Type PROCEDURE

Delivery of four acupuncture seeds (no needles involved) to the head and neck area at non-acupuncture points.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

True Acupuncture

Delivery of four acupuncture seeds (no needles involved) to the head and neck area at true acupuncture points.

Intervention Type PROCEDURE

Sham Acupuncture

Delivery of four acupuncture seeds (no needles involved) to the head and neck area at non-acupuncture points.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age greater than or equal to 18 years old
* Chronic congestive heart failure (systolic or diastolic)
* Medication list includes midodrine or fludrocortisone, either taking as scheduled or as needed

Exclusion Criteria

* History of acupuncture of any kind in the last 3 months
* Acute decompensated heart failure, as indicated by clinical picture at time of enrollment
* Currently on a mechanical device (LVAD, TAH, ECMO)
* History of hepatorenal syndrome, adrenal insufficiency, for which midodrine and fludrocortisone respectively is specifically being used to treat that condition
* Lack of suitable locations for which to place acupuncture seeds
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Scripps Health

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Yu-Ming Ni

Cardiology Fellow

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Christopher Suhar, MD

Role: PRINCIPAL_INVESTIGATOR

Scripps Health

Yu-Ming Ni, MD

Role: PRINCIPAL_INVESTIGATOR

Scripps Health

Rajeev Mohan, MD

Role: PRINCIPAL_INVESTIGATOR

Scripps Health

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Scripps La Jolla Medical Center

La Jolla, California, United States

Site Status RECRUITING

Scripps Shiley Integrative Center

La Jolla, California, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Yu-Ming Ni, MD

Role: CONTACT

858-554-3360

Christopher Suhar, MD

Role: CONTACT

858-554-3300

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Yu-Ming Ni, MD

Role: primary

858-554-3360

Christopher Suhar, MD

Role: backup

858-554-3300

Yu-Ming Ni, MD

Role: primary

858-554-3360

Christopher Suhar, MD

Role: backup

858-554-3300

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IRB-20-7569

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Hypnosis in Autonomic Function
NCT00061009 COMPLETED
Endothelin Receptor Function and Acute Stress
NCT02116335 ACTIVE_NOT_RECRUITING NA